Search the web
Sign In
New User? Sign Up
aidsnews · AIDS Treatment News announcement list
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Real people. Real stories. See how Yahoo! Groups impacts members worldwide.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
AIDS Treatment News alert, 2004-12-31 -- Nevirapine   Message List  
Reply | Forward Message #61 of 82 |
Now online at AIDS Treatment News:

*** Nevirapine Misinformation: Will It Kill?
Summary: In mid December 2004 three Associated Press stories created
widespread doubts about nevirapine, a well-known, critically important
drug that can prevent HIV in many of the 1,800 babies now infected
every day by their mothers in childbirth. The media allegations that
went around the world grew out of a bitter personal and personnel
dispute between two employees at the U.S. National Institutes of
Health. No new information about nevirapine was released; doctors know
that it still has the same risks and benefits after the newspaper
stories as before. But many experts fear that the emotions released by
the worldwide misinformation will result in many HIV-positive mothers
getting no treatment and unnecessarily infecting their children with
HIV. Here is background that has been missing in many of the news
reports. [December 31, 2004]
Full article: http://www.aidsnews.org/2004/12/nevirapine-ap.html

--
John S James
AIDS Treatment News
www.aidsnews.org




Fri Dec 31, 2004 5:00 pm

aidsnews@...
Send Email Send Email

Forward
Message #61 of 82 |
Expand Messages Author Sort by Date

Now online at AIDS Treatment News: *** Nevirapine Misinformation: Will It Kill? Summary: In mid December 2004 three Associated Press stories created widespread...
John James
aidsnews@...
Send Email
Dec 31, 2004
5:09 pm
Advanced

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help